Skip to main content

News

March 13, 2024

March 11, 2024

March 5, 2024

February 28, 2024

Patients who have drug-resistant tuberculosis (TB) have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking first-line regimens, according to research...

February 13, 2024

Research involving animal models – for purposes such as developing new vaccines or regenerative medicines – generally employ mice, but new Cornell research has identified another species that could be valuable to sup...

February 8, 2024

An interdisciplinary team of Cornell researchers has identified an innovative way to harness the antioxidant and antibacterial properties of the botanical compound lawsone to make nanofiber-coated cotton bandages that fi...

February 2, 2024

January 31, 2024

January 30, 2024

January 3, 2024

December 15, 2023

December 6, 2023

November 7, 2023

November 7, 2023

February 1, 2023

January 9, 2023

November 11, 2022

A typical gut bacterium that can spread through the body and cause a serious infection resists natural immune defenses and antibiotics by enhancing its protective outer layer, known as the cell envelope, according to a n...

November 7, 2022

Yingzheng (Jason) Wang and Misha Kazi, postdoctoral researchers at Cornell’s Weill Institute for Cell and Molecular Biology, have been named as recipients of the 2022 Sam and Nancy Fleming Research Fellowships Since 20...

November 4, 2022

Consumers would be willing to buy milk from cows only treated with antibiotics when medically necessary – as long as the price isn’t much higher than conventional milk, according to researchers at the College of Vete...

November 4, 2022

A new study from the College of Veterinary Medicine explores how willing dairy consumers are to purchase milk made by cows only treated with antibiotics when medically necessary Too much antibiotic treatment in cows lead...